Sang Mi Han

Title: **Innovator Spotlight: Sang Mi Han from Seoul, South Korea**

Introduction

Sang Mi Han is a prominent inventor based in Seoul, South Korea, recognized for his significant contributions to the field of pharmaceutical sciences. With a total of three patents under his name, Han is making strides in developing innovative treatments for diseases related to abnormal cell growth.

Latest Patents

Sang Mi Han's latest patents include groundbreaking compounds that target protein kinases, which play a crucial role in various cellular processes. His inventions include:

1. **Thieno[3,2-D]pyrimidine derivatives having inhibitory activity for protein kinases** - This patent involves a thieno[3,2-d]pyrimidine derivative or its pharmaceutically acceptable salt that exhibits inhibitory activity against protein kinases. It also encompasses a pharmaceutical composition aimed at the prevention and treatment of diseases linked to abnormal cell growth.

2. **Isoquinoline-5-carboxamide derivative having inhibitory activity for protein kinases** - This invention features a compound from the isoquinoline-5-carboxamide category, including its salts, isomers, hydrates, and solvates. These compounds are effective in the prevention and treatment of conditions associated with abnormal cell growth caused by the inappropriate activation of protein kinases.

Career Highlights

Sang Mi Han is currently employed at Hanmi Pharmaceutical Co., Ltd., where he harnesses his expertise in medicinal chemistry to develop novel therapeutic agents. His work focuses on understanding and manipulating cellular pathways to create effective solutions for severe health issues.

Collaborations

Sang has collaborated with talented colleagues such as In Hwan Bae and Eun Joo Kwak. Together, they form a dynamic team that contributes to the advancement of pharmaceutical research and development at Hanmi Pharmaceutical.

Conclusion

Through his innovative work and commitment to research, Sang Mi Han is making a substantial impact in the field of pharmaceuticals. His patents not only showcase his inventive spirit but also hold the potential to transform the landscape of treatments available for diseases driven by abnormal cell growth. As he continues to push the boundaries of science, the future of his contributions promises to be bright and influential.